Objectives Hypertensive response to exercise (HRE) always acts as a relative indication to terminate exercise during treadmill stress test and prohibit the interpretation of inadequate result. We supposed the CAVI (Cardio-ankle vascular index) might be an initial clue to predict hypertensive response to exercise. Material and methods Retrospective chart review in cardiology unit, patients who attended health preventive program in our heart hospital, and performed both CAVI and treadmill stress test in the same day between June 2018 and December 2018. Variables for prediction of HRE were analyzed, using univariate analysis and significant variables were entered in multiple logistic regression. ROC curve was created to test the sensitivity and specificity when used CAVI >8 as a cut-point of increased arterial stiffness. Results 285 patients (157 females, 55.1%) were enrolled in this study. 58 patients (20.4%) who matched with HRE definition (SBP ≥210 mmHg or DBP ≥100 mmHg in male, SBP ≥190 mmHg or DBP ≥95 mmHg in female), mean age 46.4±12.8 years. In univariate analysis; age, diabetes mellitus, hypertension, dyslipidemia, history taking beta-blocker, and CAVI result were statistically significant. Multiple logistic regression revealed only CAVI result was statistically significant predictor of HRE (OR 5.8, 95% CI: 3.5–10.9, P<0.001). ROC curve analysis of the CAVI revealed AUC 0.827 (95% CI: 0.76–0.89, p<0.001) and the sensitivity and specificity of cut-point CAVI ≥8 were 53% and 92% respectively. Conclusion This study demonstrated CAVI is an independent predictor for hypertensive response to exercise. CAVI ≥8 is not the sensitive tool but quite specific to detect HRE. Funding Acknowledgement Type of funding sources: Private hospital(s). Main funding source(s): Bangkok Dusit Medical services
OBJECTIVES Hypertensive response to exercise (HRE) is related to the development of future hypertension, cardiovascular morbidity, and mortality, independent of resting blood pressure. We hypothesized that arterial stiffness as measured by cardio-ankle vascular index (CAVI) could be an independent predictor of HRE. MATERIALS AND METHODS Retrospective chart review of patients participated in the preventive health program at the Bangkok Heart Hospital who underwent both CAVI and treadmill stress testing on the same day between June and December 2018 were performed. Variables for the prediction of HRE were analyzed using univariate analysis, and significant variables were entered into multiple logistic regression. An ROC curve was created to test the sensitivity and specificity of CAVI as a predictor of HRE. RESULTS A total of 285 participants (55.1% female) were enrolled in this study. There were 58 patients (20.4%) who met the HRE definition (SBP > 210 mmHg in males, SBP > 190 mmHg in females, or DBP > 110 mmHg in both males and females), with a mean age of 46.4 12.8 years. In univariate analysis, age, systolic blood pressure at rest, diastolic blood pressure at rest, pulse pressure at rest, diabetes mellitus, hypertension, dyslipidemia, history of beta-blocker, and CAVI results were statistically significant. Multiple logistic regression revealed that CAVI and systolic blood pressure were statistically significant predictors of HRE with OR of 5.8, 95%CI: 2.9-11.7, P<0.001 and OR 1.07, 95%CI: 1.03-1.10, P=0.001 respectively. ROC curve analysis of the CAVI revealed an AUC of 0.827 (95%CI: 0.76-0.89, p < 0.001), and the sensitivity and specificity of cut-point CAVI > 8 were 53% and 92%, respectively. CONCLUSION This study demonstrated that CAVI is an independent predictor of hypertensive response to exercise. CAVI > 8 is specific predictor of HRE.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.